Assure BrandPanels Launched to Eliminate Fraud in Pharmaceutical Market Research
P\S\L Group today introduced Assure BrandPanels to address fraud in pharmaceutical market research, as most recently highlighted by the German news organisation Der Spiegel . During an in-depth investigation encompassing 600 market research studies, including those containing physicians, Der Spiegel uncovered systematic manipulation in the industry leading to fraudulent data. Assure BrandPanels is a new product that applies artificial intelligence and machine learning to quickly uncover and prevent bad actors from infiltrating research samples.
The Der Spiegel investigation is the latest to put a spotlight on this growing threat. More and more market research samples contain fake respondents, fake credentials and fake answers, making any decisions based on the study results perilous. Many industry insiders are concerned about these threats, but don’t currently have an effective way to address them.
“Essentially today we have a system whereby a large chain of suppliers are involved in a given MR project and there is no certified way to detect fake data. This systemic problem can result in fraudulent data being used to make important decisions,” said Asif Javed, C.E.O. of Assure BrandPanels. “Assure BrandPanels applies machine learning and artificial intelligence to detect and eliminate bad respondents such as bots, Russian and Eastern European hackers and other non-physicians, all pretending to be someone they are not.”
About Assure BrandPanels
Assure BrandPanels is a custom-assembled panel comprised of a client's target physicians, used for generating sample frames for market research recruitment. Utilising the latest developments in artificial intelligence and machine learning, Assure BrandPanels eliminates fake respondents, fake credentials and fake answers from market research samples, ensuring all respondents are verified, vetted and valued.
To learn more about Assure BrandPanels, visit www.assurepanels.com
About PSL Group
P\S\L Group is a global organisation dedicated to putting information at the service of medicine. The companies and people of the P\S\L Group aim to improve medical care by serving those who need it, those who provide it and those who seek to improve it. Our clients include research-based health sciences companies and other healthcare institutions who seek the advancement of medicine. Our primary business purpose is to help these clients increase the effectiveness, as well as lower the cost, of activities pertaining to scientific communication, medical publishing or product/service marketing. Learn more at www.pslgroup.com .
Asif Javed, +44(0) 7720 880 842
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-RESMED-INC15.7.2019 22:07:07 CEST | Press release
ResMed Inc. Completes $500M Private Placement Debt Offering
SPEEDX15.7.2019 17:02:04 CEST | Press release
SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test
TX-MOUSER-ELECTRONICS15.7.2019 16:57:04 CEST | Press release
Mouser Electronics Now Stocking Broad Portfolio of Xilinx Products
CA-RIMINI-STREET15.7.2019 15:02:08 CEST | Press release
Rimini Street Becomes Support Service Provider for Hyundai-Kia Motors’ Global Database Portfolio
MN-VÄRDE-PARTNERS15.7.2019 14:14:05 CEST | Press release
Värde Partners Appoints Co-CEO
BOEHRINGER-INGELHEIM15.7.2019 14:02:04 CEST | Press release
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom